TrialPloS one2015

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer.

Sofia Agelaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.